Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase  by Knotek, Mladen et al.
Kidney International, Vol. 59 (2001), pp. 2243–2249
Endotoxemic renal failure in mice: Role of tumor necrosis
factor independent of inducible nitric oxide synthase
MLADEN KNOTEK, BORIS ROGACHEV, WEI WANG, TEVFIK ECDER, VYACHESLAV MELNIKOV,
PATRICIA E. GENGARO, MATTHEW ESSON, CHARLES L. EDELSTEIN, CHARLES A. DINARELLO,
and ROBERT W. SCHRIER
Department of Medicine, Divisions of Renal Diseases and Hypertension and Infectious Diseases, University of Colorado
Health Sciences Center, Denver, Colorado, USA
and morphological alterations, thus suggesting renal hypoper-Endotoxemic renal failure in mice: Role of tumor necrosis
fusion secondary to an imbalance between, as yet to be defined,factor independent of inducible nitric oxide synthase.
renal vasoconstrictors and vasodilators.Background. Renal failure is a frequent complication of sep-
sis with a high mortality. Tumor necrosis factor (TNF) has been
suggested to be a factor in the acute renal failure in sepsis or
endotoxemia. Recent studies also suggest involvement of nitric
The course of sepsis is frequently complicated by theoxide (NO), generated by inducible NO synthase (iNOS), in the
development of septic shock and multiorgan failure, withpathogenesis of endotoxin-induced renal failure. The present
study tested the hypothesis that the role of TNF in endotoxic a 50% mortality [1]. In a recent prospective study, acute
renal failure is mediated by iNOS-derived NO. renal failure was present in approximately 20% of pa-
Methods. Renal function was evaluated in endotoxemic [Esch- tients with severe sepsis and in 50% of patients witherichia coli lipopolysaccharide (LPS), 5 mg/kg IP] wild-type and
septic shock [1]. Many of the pathophysiological abnor-iNOS knockout mice. The effect of TNF neutralization on renal
function during endotoxemia in mice was assessed by a TNF- malities of sepsis can be reproduced in experimental
soluble receptor (TNFsRp55). animals by the administration of endotoxin, a lipopoly-
Results. An injection of LPS to wild-type mice resulted in saccharide (LPS) constituent of gram-negative bacteria
a 70% decrease in glomerular filtration rate (GFR) and in a
wall [2]. In experimental endotoxemia, renal failure in-40% reduction in renal plasma flow (RPF) 16 hours after the
volves excessive intrarenal vasoconstriction [3; reviewedinjection. The results occurred independent of hypotension,
morphological changes, apoptosis, and leukocyte accumula- in 4]. Endotoxin induces several proinflammatory cyto-
tion. In mice pretreated with TNFsRp55, only a 30% decrease kines, among which tumor necrosis factor (TNF) is
in GFR without a significant change in RPF in response to thought to be of major importance [5]. Accordingly, pas-LPS, as compared with vehicle-treated mice, was observed.
sive immunization by an anti–TNF-a antibody protectedAlso, the serum NO concentration was significantly lower in
against septic shock in baboons [6] and mice [7]. Theendotoxemic wild-type mice pretreated with TNFsRp55, as
compared with untreated endotoxemic wile-type mice (260 6 pathogenic role of TNF in endotoxemic renal failure has
52 vs. 673 6 112 mmol/L, P , 0.01). In LPS-injected iNOS been suggested. For example, an intravenous infusion of
knockout mice and wild-type mice treated with a selective
TNF-a in rabbits or perfusion of isolated rat kidney withiNOS inhibitor, 1400W, the development of renal failure was
TNF-a led to a decrease in glomerular filtration ratesimilar to that in wild-type mice. As in wild-type mice, TNFsRp55
significantly attenuated the decrease in GFR (a 33% decline, as (GFR) [8, 9].
compared with 75% without TNFsRp55) without a significant Several mechanisms have been suggested for the ef-
change in RPF in iNOS knockout mice given LPS. fects of LPS/TNF on organ function during endotoxemia.Conclusions. These results demonstrate a role of TNF in the
These include reduced organ perfusion due to systemicearly renal dysfunction (16 h) in a septic mouse model indepen-
hypotension, apoptosis, leukocyte accumulation and in-dent of iNOS, hypotension, apoptosis, leukocyte accumulation,
flammation, and fibrin deposition [10–16]. Nitric oxide
(NO) has also attracted attention as a mediator of hypo-
tension and organ failure in experimental endotoxemiaKey words: acute renal failure, sepsis, renal vasoconstriction, lipopoly-
saccharide, hypertension, blood pressure. and sepsis in patients and laboratory animals. NO is syn-
thesized by the three NO synthase (NOS) isoenzymes:
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On the other hand, iNOS is induced in various cell types before each experiment. It was administered in a dose
of 20 mg/kg intraperitoneally at 1 and 12 hours after(for example, vascular smooth muscle cells and macro-
LPS. If not stated otherwise, chemicals were purchasedphages) in response to stimulation by LPS, cytokines
from Sigma (St. Louis, MO, USA).[TNF-a, interferon-g (IFN-g), interleukin-1b (IL-1b)]
[17], or hypoxia [18], whereby it mediates NO overpro-
Experimental modelduction. Although NO has been proposed as a mediator
Twelve hours following injection of LPS, mice wereof renal dysfunction in endotoxemia, the use of nonselec-
anesthetized with an intraperitoneal injection of 2,2,2tive NOS inhibition leads to further deterioration of re-
tribromoethanol (Avertin; Aldrich, Milwaukee, WI,nal function [19]. Selective inhibition of iNOS, which
USA). Supplemental injections of the anesthetic weremay be an alternative to avoid endothelial dysfunction,
administered as needed to maintain the mice in a sedatedresulted in conflicting data with either improvement
state throughout the procedure, and the animals were[19, 20] or lack of an effect on LPS-induced renal failure
kept on a heating pad. Right internal jugular vein and[21, 22].
carotid artery were catheterized using a PE10 catheterA majority of the studies described previously in this
connected to a PE50 catheter. The urinary bladder wasarticle were performed using models of established septic
catheterized with a PE50 catheter, after incision of theshock with severe systemic hypotension. Moreover, the
bladder fundus. Mice were infused intravenously withmechanisms proposed were reported to occur at later
6% albumin solution in isotonic saline at a rate of 3.5 mL/time points (greater than 24 hours) in the course of
min during the entire procedure.endotoxemia. The purpose of the present study, there-
fore, was to examine the potential mechanisms involved Mean arterial pressure measurement
in endotoxic renal failure at earlier time points (less than
Intracarotid mean arterial pressure (MAP) was mea-24 hours) using a normotensive model of endotoxemia.
sured using a Spectramed Statham transducer connectedThe role of TNF was tested by measuring renal function
to a model 7P1K low-level DC preamplifier and was readin the presence of TNF neutralization. In order to exam-
on a model 79 Grass polygraph.ine whether the effect of TNF on renal function is medi-
ated by iNOS induction, renal function was also assessed Clearances
in endotoxemic iNOS knockout mice. Furthermore,
A saline solution of inulin (50 g/L) and paraaminohip-based on previous reports, we examined renal tissue for
puric acid (PAH; 10 g/L) was intravenously infused intra-
evidence of early apoptosis, leukocyte accumulation, or jugularly for 75 minutes at a rate of 3.5 mL/min using a
morphological changes that could contribute to the early KD Scientific model 200 infusion pump before three con-
reduction in GFR in endotoxemia. secutive 30-minute urine samples were collected. Urine
volume was determined by weight. A blood sample was
withdrawn after the last urine collection. Urine and se-METHODS
rum inulin and PAH concentrations were determinedMice and reagents
spectrophotometrically. Clearances were calculated as a
Experiments were carried out using male B6,129F2/J ratio between mean urinary excretion rates of inulin or
and iNOS knockout B6129 mice weighing 20 to 30 g, PAH and serum concentrations of inulin or PAH per
purchased from Jackson Laboratories, (Bar Harbor, ME, 100 g body wt.
USA). Studies of renal function were conducted in mice
injected intraperitoneally with 5 mg/kg of Escherichia NO measurement
coli LPS (Difco, Detroit, MI, USA). A saline solution Serum NO was measured by chemiluminescence with
of LPS (0.75 mg/mL) was freshly prepared before each NaNO3 as a standard using a NO analyzer (Sievers Instr.,
experiment. The soluble TNF receptor TNFsRp55 that Inc., Boulder, CO, USA).
was used in this study was kindly supplied by Dr. Carl
Tissue analysesK. Edwards (Amgen, Inc., Thousand Oaks, CA, USA).
TNFsRp55 is a construct of the extracellular four do- All tissue analyses were conducted 16 hours after LPS
mains of the TNFRp55 in which two chains of the extra- injection. Tissue samples were fixed in 4% paraformalde-
cellular domains are linked by a polyethylene bridge [23]. hyde and were paraffin embedded. Samples were exam-
The soluble receptor was kept at 2708C until thawed ined for evidence of apoptosis using the terminal deoxy-
once, diluted in saline, and used in experimental studies nucleotidyl transferase (TdT)-mediated nick-end labeling
as previously described [24]. TNFsRp55 (10 mg/kg) was (TUNEL) method to detect in situ DNA strand breaks
administered intraperitoneally one hour before an intra- (TACS 2 TdT-blue label in situ apoptosis detection kit;
peritoneal injection of LPS. 1400W, a selective iNOS Trevigen, Inc., Gaithersburg, MD, USA). Other paraffin-
inhibitor (purchased from Alexis Corp., San Diego, CA, embedded samples were stained with hematoxylin and
eosin for morphological examination.USA) [25] was freshly dissolved in saline (3 mg/mL)
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Fig. 1. Endotoxic renal failure in wild-type mice. Glomerular filtration rate (GFR; A) and renal plasma flow (RPF; B) were determined at 4 and
16 hours after an injection of 5 mg/kg intraperitoneal endotoxin. Data are expressed as mean 6 SEM, N 5 6. *P , 0.05 vs. control by ANOVA.
Neutrophil accumulation was assessed on acetone- mice were treated with higher doses of LPS, the urinary
sodium concentration, measured 24 hours after LPS, wasfixed tissue sections by an indirect immunofluorescent
technique using a rat anti-mouse neutrophil antibody lower in the LPS-treated mice (data not shown). These
findings are compatible with renal hypoperfusion and(Serotec Inc., Raleigh, NC, USA). Leukocyte accumula-
tion was also determined by measuring myeloperoxidase intact tubular function.
activity of snap-frozen kidney samples by the method of
Effect of TNF neutralization on renal function andLaight et al [26].
serum NO in wild-type mice
Statistical analyses In these experiments, renal function was evaluated at
16 hours after administration of LPS. Pretreatment ofValues are expressed as mean 6 SEM. Multiple-
group comparisons were assessed by analysis of variance mice with TNFsRp55 (10 mg/kg IP, 1 hour before LPS)
resulted in less of a decrease in GFR (30%) as compared(ANOVA) using the post hoc Newman–Keuls test. P ,
0.05 was considered statistically significant. with LPS-treated mice given vehicle instead of TNFsRp55,
in which GFR fell by 75% (Fig. 2A). After TNFsRp55
pretreatment, no decrease in RPF from control levels
RESULTS
was observed (Fig. 2B). At the same time, the serum
Endotoxic renal failure in wild-type mice NO level in endotoxemic mice was reduced with
TNFsRp55, as compared with LPS-treated mice givenTo induce renal failure, mice were injected intraperito-
neally with 5 mg/kg LPS, a relatively low, nonlethal dose vehicle (673 6 112 vs. 260 6 52 mmol/L, N 5 6, P ,
0.01), indicating suppressed induction of iNOS. Thereof LPS that permitted surgery and physiological mea-
surements without an excessive mortality. In addition, was no significant difference in MAP between the three
groups 16 hours following injection of vehicle or LPSwith this dose of LPS, it was possible to evaluate renal
function in the absence of severe hypotension (MAP, (102 6 5 vs. 92 6 6 vs. 94 6 4 mm Hg; N 5 4 to 6, P 5
NS; control vs. LPS vs. LPS 1 TNFsRp55).110 6 9 mm Hg in vehicle-injected vs. 101 6 8 mm Hg
in treated with LPS, N 5 5, P 5 NS). After 16 hours,
Renal function in iNOS knockout miceendotoxemia resulted in an elevation in serum NO con-
centration, as compared with vehicle-injected mice Endotoxemia did not change the serum NO concentra-
tion measured after 16 hours in iNOS knockout mice in(647 6 178 mmol/L vs. 24 6 4 mmol/L, N 5 4, P , 0.05).
Renal clearances of PAH and inulin were determined response to LPS (28.2 6 7.2 vs. 40.9 6 5.2 mmol/L, P 5
NS). However, in iNOS knockout mice, GFR decreasedat 4 and 16 hours following an injection of LPS. As
shown in Figure 1A, GFR decreased significantly four in response to LPS by 70% and RPF by 65% (Fig. 3).
There was no change in MAP in response to LPS (107 6hours after the administration of LPS. At 16 hours, GFR
in LPS-treated mice decreased to 30% of control value 5 vs. 116 6 8 mm Hg, N 5 4, P 5 NS; control vs. LPS).
Similarly, treatment of wild-type mice with a selective(Fig. 1A). Changes in renal plasma flow (RPF) followed
a similar pattern (Fig. 1B). There were no morphological iNOS inhibitor, 1400W, did not prevent decrease in GFR
in response to LPS (0.25 6 0.04 mL/min 100 g bodychanges in the kidneys of LPS treated mice compared
with controls. Moreover, in other studies in which the weight vs. 0.25 6 0.06 mL/min 100 g body weight, N 5
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Fig. 2. Effect of TNFsRp55 (10 mg/kg IP) on renal function in wild-type mice. Mice were pretreated with TNFsRp55 for one hour before the
administration of 5 mg/kg intraperitoneal endotoxin. GFR (A) and RPF (B) were determined 16 hours thereafter. Data are expressed as mean 6
SEM, N 5 6. *P , 0.05 vs. Control; §P , 0.05 vs. LPS, by ANOVA.
4, P 5 NS; LPS vs. LPS 1 1400W), although the serum DISCUSSION
NO concentration decreased significantly (149 6 27 vs. In the present study, a model of LPS-induced renal
355 6 65 mmol/L, N 5 4, P , 0.05) with 1400W treat- failure in mice was developed. Use of a relatively low
ment. MAP was not significantly influenced by 1400W dose of LPS permitted the study of renal function in the
(97 6 5 vs. 105 6 6 mm Hg, N 5 4, P 5 NS; LPS vs. absence of hypotension and mortality. The administra-
LPS 1 1400W). tion of LPS to wild-type mice decreased renal function
in a time-dependent manner. Thus, renal failure in the
Effect of TNF neutralization on renal function in present study occurred in the absence of systemic hypo-
iNOS knockout mice tension, similar to previous work in rats [3]. Since TNF-a
is a proinflammatory cytokine in endotoxemia and sepsisTo check whether the protective effect of TNF neutral-
[5], the role of this cytokine in the renal failure wasization is preserved in LPS-treated iNOS knockout mice,
examined. Importantly, neutralization of TNF, usingrenal function was evaluated in mice given TNFsRp55
TNFsRp55, afforded protection against LPS-induced re-one hour before LPS. Similar to wild-type mice, pretreat-
nal failure in wild-type mice. With the pretreatment withment of iNOS knockout mice with TNFsRp55 attenuated
TNFsRp55, GFR decreased only by 30%, as comparedrenal dysfunction in response to LPS (Fig. 4A). Endotox-
with a 75% decrease without TNF neutralization. More-emic iNOS knockout mice pretreated with 10 mg/kg
over, TNFsRp55 prevented the fall in RPF in responseTNFsRp55 had less of a decrease in GFR (35%) as
to LPS. These findings suggested a functional role ofcompared with LPS-treated iNOS knockout mice given
TNF in the pathogenesis of endotoxin-associated renalvehicle instead of TNFsRp55, in which GFR fell by 75%.
failure, as proposed in previous studies [8, 9]. In rabbits,Again, RPF was not different than controls in the
an intravenous infusion of TNF-a induced glomerular
TNFsRp55-treated animals (Fig. 4B). In addition, MAP
fibrin deposition and renal failure [9]. Similarly, in the
did not change in response to LPS and TNF blockade
perfused rat kidney, TNF-a led to a decrease in GFR [8].
(98 6 7 vs. 103 6 7 vs. 99 6 8 mm Hg, N 5 4 to 6, NS, Since the discovery that hypotensive effects of TNF-a
control vs. LPS vs. LPS 1 TNFsRp55). and endotoxin could be blocked by inhibition of NOS
[27, 28], the role of NO in the hypotension and organ
Tissue analyses failure in endotoxemia or sepsis has become the subject
No evidence of apoptosis was observed as assessed by of several studies. NO is generated by the three NOS
TUNEL staining at 16 hours after LPS treatment in wild- isoenzymes. The constitutively expressed NOSs (nNOS
type mice. Morphologically, the kidneys appeared un- and eNOS) are regulated by changes in intracellular cal-
changed by light microscopy. In addition, no significant cium, whereas the inducible isoform, iNOS, does not
leukocyte accumulation could be detected at 16 hours require calcium and is primarily regulated at the tran-
by either neutrophil staining or measurement of myelo- scription level [17]. The eNOS-mediation of NO produc-
tion participates in the regulation of normal vascularperoxidase activity.
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Fig. 3. Endotoxic renal failure in inducible nitric oxide synthase (iNOS) knockout mice. GFR (A) and RPF (B) were determined at 4 and 16
hours after injection of 5 mg/kg intraperitoneal endotoxin. Data are expressed as mean 6 SEM, N 5 6. *P , 0.05 vs. Control, by ANOVA.
tone. Endotoxin is a potent inducer of iNOS directly and not provide protection against endotoxemic renal failure
in this nonhypotensive endotoxemic model in mice. Inthrough its cytokine mediators TNF-a, IFN-g, and IL-1b
[17]. iNOS-derived NO has been implicated as a media- previous studies, iNOS inhibitors improved glomerular
filtration [19, 20], whereas there was no effect in otherstor of renal failure in endotoxemia [19–22]. Experiments
using nonselective NOS blockade frequently resulted in [21, 22]. In these studies, renal function was evaluated
in anesthetized animals after a relatively short period ofa worsening of renal function due to increased renal vaso-
constriction [19]. In addition, nonselective NOS block- endotoxemia. In the present study, the effect of anesthe-
sia on renal function was avoided by using sedated mice.ade was shown to promote glomerular thrombosis in
endotoxemic rats [29]. Thus, selective inhibition of iNOS Also, our experiments started at 12 hours after LPS,
when iNOS was clearly induced in wild-type mice, ascould be an alternative strategy to avoid endothelial dys-
function after nonselective NOS inhibition. We hypothe- serum NO increased markedly at that time. In contrast
to the failure to incriminate NO, TNF neutralizationsized that suppression of iNOS by TNF neutralization
may reduce LPS-induced renal failure. Indeed, pretreat- by a soluble receptor attenuated renal failure in iNOS
knockout mice. Similar to wild-type mice, in endotoxe-ment of mice with TNFsRp55 reduced the increase in
serum NO in response to LPS. Similar results have been mic iNOS knockout mice pretreated with TNFsRp55,
GFR fell by only 33%, without a reduction in RPF,reported in cultured rat brain cells in which either
TNFsRp55 or an IL-1 receptor antagonist produced a as compared with a 75% decrease in GFR and a 40%
decrease in RPF without TNFsRp55 pretreatment.dose-dependent partial inhibition of the NO response to
LPS [30]. Although TNFsRp55 binds directly to TNF, it There are numerous mechanisms whereby TNF-a may
contribute to renal failure in endotoxemia. Many of theis possible that other downstream cytokines could be
affected. However, as indicated by only partial inhibition changes that have previously been reported to occur and
contribute to the resultant organ failure of endotoxemiaof LPS-induced NO in wild-type mice treated with
TNFsRp55, all mediators of iNOS induction were clearly were observed in models of established septic shock with
severe systemic hypotension. Moreover, these events oc-not blocked in our studies. Moreover, Faggioni et al have
shown that IFN-g levels are not reduced by TNFsRp55 curred mainly at later time points (later than 24 hours)
in the course of endotoxemia. In the present study, how-in a model of ConA-induced hepatotoxicity [24].
The present results, however, do not support a major ever, as discussed previously in this article, we developed
a normotensive model of endotoxemia and examinedrole of iNOS in endotoxemic renal failure. Specifically,
the degree of renal failure (a 70% decrease in GFR) time points earlier in the course of endotoxemia (4 and
16 hours). We could therefore eliminate the role of re-was similar in iNOS knockout or 1400W-treated mice
as compared with endotoxemic wild-type mice. iNOS duced renal perfusion pressure as a potential mechanism
of the LPS/TNF-induced renal failure in our study. Addi-knockout mice did not increase serum NO in response
to LPS, while endotoxemic wild-type mice treated with tionally, as discussed previously in this article, the results
of our study eliminated iNOS-mediated NO production1400W significantly decreased the serum NO concentra-
tion, as compared with untreated endotoxemic wild-type as a mechanism of the early renal dysfunction since (1)
the endotoxemic iNOS knockout mice had similar renalmice. These findings suggest that inhibition of iNOS does
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Fig. 4. Effect of TNFsRp55 (10 mg/kg IP) on renal function in iNOS knockout mice. Mice were pretreated with TNFsRp55 one hour before the
administration of 5 mg/kg intraperitoneal endotoxin. GFR (A) and RPF (B) were determined 16 hours thereafter. Data are expressed as mean 6
SEM, N 5 4 to 6. *P , 0.05 vs. Control; §P , 0.05 vs. Control and LPS, by ANOVA.
dysfunction as the endotoxemic wild-type mice, and (2) anisms will require the use of kidney-selective blockers
that preserve systemic blood pressure.the wild-type and iNOS knockout mice were similarly
The present results have important clinical implica-protected by TNF neutralization. Other mechanisms by
tions. Mortality of patients with septic shock and renalwhich TNF-a has been suggested to induce renal injury
failure remains high [1]. Although a nonselective NOSand dysfunction include glomerular fibrin deposition [9],
inhibition may exert a beneficial effect on MAP in patientsand renal endothelial, mesangial, or tubular cell apoptosis
with septic shock, a recent randomized, placebo-con-due to up-regulation of Fas and activation of caspase 3
trolled trial with a nonselective NOS inhibitor, L-NMMA,[11, 12]. In our model, however, morphological examina-
in patients with septic shock was discontinued early be-tion showed no evidence of renal fibrin deposition or
cause of an increased mortality in the treated grouppathology in either the wild-type or iNOS knockout
[32]. The present results suggest that a more promisingmice. Similarly, no apoptosis was observed in kidneys
approach may involve the blockade of the action of TNF.from LPS-treated wild-type mice as detected by TUNEL
In summary, the present study demonstrates a protec-
staining. Furthermore, renal leukocyte accumulation was
tive effect of TNF neutralization on renal function in non-
not observed in our study as assessed by neutrophil- hypotensive endotoxemia in wild-type and iNOS knock-
specific staining or myeloperoxidase activity. In this re- out mice. The deleterious effect of TNF at 4 and 16 hours
gard, Ysebaert, DeGreef, and Vercauteren have recently after LPS administration to impair renal function was
reported that myeloperoxidase activity reflects not only demonstrated to be independent of diminished renal ar-
neutrophil accumulation/activation, but also the pres- terial pressure, apoptosis, leukocyte accumulation, and
ence of monocytes or macrophages [31]. Therefore, the iNOS. These results suggest that early in mouse sepsis
lack of any increase in myeloperoxidase activity in our an imbalance between as yet unidentified renal vasocon-
study indicates that no significant accumulation or activa- strictors and vasodilators mediates the renal dysfunction.
tion of either neutrophils or monocytes/macrophages oc-
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synthase; GFR, glomerular filtration rate; IFN-g, interferon-g; IL-1b;namics. Therefore, future studies to explore these mech-
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interleukin-1b; iNOS, inducible nitric oxide synthase; LPS, lipopolysac- 17. Morris SM Jr, Billiar TR: New insights into the regulation of
inducible nitric oxide synthesis. Am J Physiol 266:E829–E839, 1994charide; MAP, mean arterial pressure; nNOS, neuronal nitric oxide
synthase; NO, nitric oxide; NOS, nitric oxide synthase; PAH, puroamino- 18. Melillo G, Musso T, Sica A, et al: A hypoxia-responsive element
mediates a novel pathway of activation of the inducible nitric oxidehippuric acid; RPF, renal plasma flow; TdT-TUNEL, terminal deoxy-
nucleotidyl transferase–mediated nick-end labeling; TNF, tumor necro- synthase promoter. J Exp Med 182:1683–1693, 1995
19. Schwartz D, Mendonca M, Schwartz I, et al: Inhibition of consti-sis factor; TNFsRp55, tumor necrosis factor soluble receptor; 1400W,
selective iNOS inhibitor. tutive nitric oxide synthase (NOS) by nitric oxide generated by
inducible NOS after lipopolysaccharide administration provokes
renal dysfunction in rats. J Clin Invest 100:439–448, 1997
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